Hisamitsu Pharmaceutical's market value is the price at which a share of Hisamitsu Pharmaceutical trades on a public exchange. It measures the collective expectations of Hisamitsu Pharmaceutical Co investors about its performance. Hisamitsu Pharmaceutical is trading at 25.80 as of the 10th of January 2025. This is a 4.88 percent increase since the beginning of the trading day. The stock's lowest day price was 25.8. With this module, you can estimate the performance of a buy and hold strategy of Hisamitsu Pharmaceutical Co and determine expected loss or profit from investing in Hisamitsu Pharmaceutical over a given investment horizon. Check out Hisamitsu Pharmaceutical Correlation, Hisamitsu Pharmaceutical Volatility and Hisamitsu Pharmaceutical Alpha and Beta module to complement your research on Hisamitsu Pharmaceutical.
Please note, there is a significant difference between Hisamitsu Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hisamitsu Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hisamitsu Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Hisamitsu Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Hisamitsu Pharmaceutical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Hisamitsu Pharmaceutical.
0.00
01/21/2023
No Change 0.00
0.0
In 1 year 11 months and 22 days
01/10/2025
0.00
If you would invest 0.00 in Hisamitsu Pharmaceutical on January 21, 2023 and sell it all today you would earn a total of 0.00 from holding Hisamitsu Pharmaceutical Co or generate 0.0% return on investment in Hisamitsu Pharmaceutical over 720 days. Hisamitsu Pharmaceutical is related to or competes with CHINA EDUCATION, Grand Canyon, AGNC INVESTMENT, MidCap Financial, and Virtus Investment. Hisamitsu Pharmaceutical Co., Inc. engages in the research and development, manufacture, purchase, and sale of pharmaceu... More
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Hisamitsu Pharmaceutical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Hisamitsu Pharmaceutical Co upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hisamitsu Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Hisamitsu Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use Hisamitsu Pharmaceutical historical prices to predict the future Hisamitsu Pharmaceutical's volatility.
At this point, Hisamitsu Pharmaceutical is very steady. Hisamitsu Pharmaceutical holds Efficiency (Sharpe) Ratio of 0.0752, which attests that the entity had a 0.0752% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Hisamitsu Pharmaceutical, which you can use to evaluate the volatility of the firm. Please check out Hisamitsu Pharmaceutical's Risk Adjusted Performance of 0.0549, downside deviation of 2.2, and Market Risk Adjusted Performance of 0.3695 to validate if the risk estimate we provide is consistent with the expected return of 0.1%. Hisamitsu Pharmaceutical has a performance score of 5 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.34, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Hisamitsu Pharmaceutical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Hisamitsu Pharmaceutical is expected to be smaller as well. Hisamitsu Pharmaceutical right now retains a risk of 1.36%. Please check out Hisamitsu Pharmaceutical sortino ratio, potential upside, skewness, as well as the relationship between the maximum drawdown and semi variance , to decide if Hisamitsu Pharmaceutical will be following its current trending patterns.
Auto-correlation
0.62
Good predictability
Hisamitsu Pharmaceutical Co has good predictability. Overlapping area represents the amount of predictability between Hisamitsu Pharmaceutical time series from 21st of January 2023 to 16th of January 2024 and 16th of January 2024 to 10th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Hisamitsu Pharmaceutical price movement. The serial correlation of 0.62 indicates that roughly 62.0% of current Hisamitsu Pharmaceutical price fluctuation can be explain by its past prices.
Correlation Coefficient
0.62
Spearman Rank Test
0.39
Residual Average
0.0
Price Variance
2.52
Hisamitsu Pharmaceutical lagged returns against current returns
Autocorrelation, which is Hisamitsu Pharmaceutical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Hisamitsu Pharmaceutical's stock expected returns. We can calculate the autocorrelation of Hisamitsu Pharmaceutical returns to help us make a trade decision. For example, suppose you find that Hisamitsu Pharmaceutical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Hisamitsu Pharmaceutical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Hisamitsu Pharmaceutical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Hisamitsu Pharmaceutical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Hisamitsu Pharmaceutical stock over time.
Current vs Lagged Prices
Timeline
Hisamitsu Pharmaceutical Lagged Returns
When evaluating Hisamitsu Pharmaceutical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Hisamitsu Pharmaceutical stock have on its future price. Hisamitsu Pharmaceutical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Hisamitsu Pharmaceutical autocorrelation shows the relationship between Hisamitsu Pharmaceutical stock current value and its past values and can show if there is a momentum factor associated with investing in Hisamitsu Pharmaceutical Co.
Hisamitsu Pharmaceutical financial ratios help investors to determine whether Hisamitsu Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hisamitsu with respect to the benefits of owning Hisamitsu Pharmaceutical security.